NRG-BN012: A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases
Principal Investigator
Study Number
STUDY02001911
Summary
This study is for patients who are having surgery to treat cancer that has spread to their brain. Researchers want to learn if giving radiation before surgery is a better or worse treatment approach than having surgery then receiving radiation (usual approach) to improve a participant’s length of time without cancer in the brain returning, getting worse, or causing scarring in the brain. Participants will be randomly place in one of two groups: one will receive radiation before surgery and one group will receive radiation after surgery. After surgery, all participants will be followed every month for 2 years, then every 6 months for 2 years.
Phase
III
Contact
Available at the following location(s)
- Lebanon
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms